SBS is a rare but serious condition which may either be associated with congenital conditions or follow bowel resection. Patients with short bowel syndrome (SBS) have a rapid intestinal transit time ...
In the absence of registry data, it is impossible to know the precise incidence and prevalence of short bowel syndrome in the United States. On the basis of European data, the incidence of total ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Apraglutide reduced weekly dependency on parenteral ...
Please provide your email address to receive an email when new articles are posted on . At 1 year, apraglutide reduced parenteral support volume by 52% in patients with short bowel syndrome with ...
In pediatric patients with short-bowel syndrome on total parenteral nutrition, catheter salvage therapy demonstrated positive outcomes and was effective for central line-associated bloodstream ...
Jaguar to host investor webcast today at 8:30 AM Eastern to review the initial results from the proof-of-concept study of crofelemer for MVID and SBS-IF presented April 26 at the Annual ELITE PED-GI ...
Hyponatremia in clinically euvolemic patients receiving chemotherapy for solid tumours. Symptom burden, quality of life, and distress in acute myeloid leukemia patients receiving induction ...
WASHINGTON -- Apraglutide, an investigational long-acting synthetic GLP-2 analog, reduced the need for parenteral support in patients with short bowel syndrome and intestinal failure (SBS-IF), a phase ...
Fluid and electrolyte management is the most critical part of medical management for the patient with short bowel syndrome. Virtually no patient with this disorder requires macronutrient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results